Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma

Br J Haematol. 2010 Mar;148(5):810-2. doi: 10.1111/j.1365-2141.2009.07998.x. Epub 2009 Nov 16.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Doxorubicin / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Middle Aged
  • Pyrazines / administration & dosage*
  • Rituximab
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Boronic Acids
  • Pyrazines
  • Rituximab
  • Bortezomib
  • Doxorubicin
  • Vidarabine
  • fludarabine